MOESM2 of The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies

Jonathan D Campbell (Contributor)
Robert Perry (Contributor)
Nikolaos G. Papadopoulos (Contributor)
Jerry Krishnan (Contributor)
Guy Brusselle (Contributor)
Alison Chisholm (Contributor)
Leif Bjermer (Contributor)
Michael Thomas (Contributor)
Eric Van Ganse (Contributor)
Maarten van den Berge (Contributor)
Jennifer Quint (Contributor)
David Price (Contributor)
Nicolas Roche (Contributor)

Dataset

1 Article

1 resultaten

Filter

2019
The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies
Campbell, J. D., Perry, R., Papadopoulos, N. G., Krishnan, J., Brusselle, G., Chisholm, A., Bjermer, L., Thomas, M., van Ganse, E., van den Berge, M., Quint, J., Price, D. & Roche, N., 27-mrt.-2019, In: Clinical and translational allergy. 9, 11 blz., 21.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand
26 Citaten (Scopus)

306 Downloads (Pure)